Considering Disclosure Risks In Sensitive Product Recalls
A New York trial judge recently denied a pharmaceutical company's motion to seal status reports between the company and the U.S. Food and Drug Administration concerning recalls of contaminated vitamin products. The...To view the full article, register now.
Already a subscriber? Click here to view full article